New COVID-19 Monoclonal Antibody Data Could Shift Clinical Practice

New data from phase 3 trials of monoclonal antibodies for patients with recent COVID-19 diagnoses, or at high risk for SARS-CoV-2 infection, could move the needle on clinician acceptance of the treatments, experts say. Two monoclonal antibody formulations, Eli Lilly’s bamlanivimab and Regeneron’s cocktail of two antibodies, casirivimab and imdevimab, received emergency use authorizations from […] Read More

COVID-19 Vaccine FAQ

We all want this pandemic to end. By February 2021, the COVID-19 pandemic caused 100 million confirmed infections and 2.2 million deaths worldwide. In the United States, 26 million people have been infected with COVID-19 and nearly 500,000 people have died. This winter, 3,300 U.S. lives were lost every day to a surge of COVID-19 […] Read More

Long-Term Effects of COVID-19

CDC is actively working to learn more about the whole range of short- and long-term health effects associated with COVID-19. As the pandemic unfolds, we are learning that many organs besides the lungs are affected by COVID-19 and there are many ways the infection can affect someone’s health. While most persons with COVID-19 recover and […] Read More